BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Fundamental Analysis & Valuation

NASDAQ:BTSGU • US10950A2050

137.415 USD
-1.99 (-1.42%)
Last: Mar 3, 2026, 08:00 PM

This BTSGU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

BTSGU gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. The financial health of BTSGU is average, but there are quite some concerns on its profitability. While showing a medium growth rate, BTSGU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. BTSGU Profitability Analysis

1.1 Basic Checks

  • BTSGU had positive earnings in the past year.
  • BTSGU had a positive operating cash flow in the past year.
  • BTSGU had negative earnings in 4 of the past 5 years.
  • In multiple years BTSGU reported negative operating cash flow during the last 5 years.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.14%, BTSGU is in line with its industry, outperforming 56.44% of the companies in the same industry.
  • BTSGU's Return On Equity of 7.13% is fine compared to the rest of the industry. BTSGU outperforms 62.38% of its industry peers.
  • BTSGU has a Return On Invested Capital (4.68%) which is comparable to the rest of the industry.
  • BTSGU had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.13%.
  • The last Return On Invested Capital (4.68%) for BTSGU is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROIC 4.68%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • BTSGU has a Profit Margin (1.04%) which is in line with its industry peers.
  • BTSGU has a Operating Margin (2.15%) which is comparable to the rest of the industry.
  • BTSGU's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 12.30%, BTSGU is doing worse than 70.30% of the companies in the same industry.
  • BTSGU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. BTSGU Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSGU is destroying value.
  • There is no outstanding debt for BTSGU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • BTSGU has an Altman-Z score of 6.19. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
  • BTSGU has a better Altman-Z score (6.19) than 92.08% of its industry peers.
  • The Debt to FCF ratio of BTSGU is 9.17, which is on the high side as it means it would take BTSGU, 9.17 years of fcf income to pay off all of its debts.
  • BTSGU's Debt to FCF ratio of 9.17 is in line compared to the rest of the industry. BTSGU outperforms 47.52% of its industry peers.
  • BTSGU has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of BTSGU (1.36) is worse than 67.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Altman-Z 6.19
ROIC/WACC0.56
WACC8.37%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.79 indicates that BTSGU should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.79, BTSGU is doing good in the industry, outperforming 71.29% of the companies in the same industry.
  • BTSGU has a Quick Ratio of 1.38. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSGU's Quick ratio of 1.38 is in line compared to the rest of the industry. BTSGU outperforms 56.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.38
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. BTSGU Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 105.45% over the past year.
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.31%

3.2 Future

  • BTSGU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.03% yearly.
  • BTSGU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.97% yearly.
EPS Next Y22.73%
EPS Next 2Y23.46%
EPS Next 3Y24.02%
EPS Next 5Y36.03%
Revenue Next Year15.67%
Revenue Next 2Y13.91%
Revenue Next 3Y15.99%
Revenue Next 5Y16.97%

3.3 Evolution

BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

1

4. BTSGU Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 121.61, the valuation of BTSGU can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of BTSGU is on the same level as its industry peers.
  • BTSGU is valuated expensively when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 99.09, the valuation of BTSGU can be described as expensive.
  • Based on the Price/Forward Earnings ratio, BTSGU is valued a bit more expensive than 60.40% of the companies in the same industry.
  • BTSGU is valuated expensively when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 121.61
Fwd PE 99.09
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • BTSGU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BTSGU is more expensive than 63.37% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSGU is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 96.33
EV/EBITDA 65
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BTSGU's earnings are expected to grow with 24.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.35
PEG (5Y)N/A
EPS Next 2Y23.46%
EPS Next 3Y24.02%

3

5. BTSGU Dividend Analysis

5.1 Amount

  • BTSGU has a Yearly Dividend Yield of 2.46%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.48, BTSGU pays a better dividend. On top of this BTSGU pays more dividend than 95.05% of the companies listed in the same industry.
  • BTSGU's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

  • BTSGU has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2Y23.46%
EPS Next 3Y24.02%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BTSGU Fundamentals: All Metrics, Ratios and Statistics

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (3/3/2026, 8:00:02 PM)

137.415

-1.99 (-1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners73.18%
Inst Owner ChangeN/A
Ins Owners2.49%
Ins Owner ChangeN/A
Market Cap26.60B
Revenue(TTM)N/A
Net Income(TTM)129.59M
Analysts86.36
Price Target150.17 (9.28%)
Short Float %0.01%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.59%
PT rev (3m)10.47%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 121.61
Fwd PE 99.09
P/S 2.14
P/FCF 96.33
P/OCF 76.16
P/B 14.62
P/tB N/A
EV/EBITDA 65
EPS(TTM)1.13
EY0.82%
EPS(NY)1.39
Fwd EY1.01%
FCF(TTM)1.43
FCFY1.04%
OCF(TTM)1.8
OCFY1.31%
SpS64.14
BVpS9.4
TBVpS-5.55
PEG (NY)5.35
PEG (5Y)N/A
Graham Number15.46
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROCE 5.92%
ROIC 4.68%
ROICexc 4.83%
ROICexgc 14.34%
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
FCFM 2.22%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Debt/EBITDA 5.55
Cap/Depr 40.71%
Cap/Sales 0.59%
Interest Coverage 1.44
Cash Conversion 78.31%
Profit Quality 213.06%
Current Ratio 1.79
Quick Ratio 1.38
Altman-Z 6.19
F-Score7
WACC8.37%
ROIC/WACC0.56
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y22.73%
EPS Next 2Y23.46%
EPS Next 3Y24.02%
EPS Next 5Y36.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.31%
Revenue Next Year15.67%
Revenue Next 2Y13.91%
Revenue Next 3Y15.99%
Revenue Next 5Y16.97%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year63.51%
EBIT Next 3Y31.78%
EBIT Next 5Y29.04%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 / BTSGU FAQ

What is the fundamental rating for BTSGU stock?

ChartMill assigns a fundamental rating of 3 / 10 to BTSGU.


Can you provide the valuation status for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27?

ChartMill assigns a valuation rating of 1 / 10 to BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU). This can be considered as Overvalued.


Can you provide the profitability details for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27?

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) has a profitability rating of 3 / 10.


What are the PE and PB ratios of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) stock?

The Price/Earnings (PE) ratio for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 121.61 and the Price/Book (PB) ratio is 14.62.


Can you provide the financial health for BTSGU stock?

The financial health rating of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 4 / 10.